Corneal Transplant Market Size, Share, Growth Analysis, By Indications(Fungal corneal ulcer, Bullous keratopathy, Keratoconus, Keratitis), By Type(Penetrating keratoplasty, Endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty (DSAEK), Corneal graft), By End-user(Hospitals, Eye clinics, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2814 | Region: Global | Published Date: July, 2024
Pages: 219 |Tables: 96 |Figures: 66

Corneal Transplant Market Insights

Global Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031). 

As per a report released by the National Institutes of Health (NIH), an estimated 10-15% of patients diagnosed with keratoconus necessitate undergoing a corneal implant procedure at some stage of their treatment. This underscores the significance of corneal implants in managing and addressing the impact of keratoconus, a condition that affects a notable portion of the population. Moreover, corneal blindness emerges as a substantial global health concern, ranking as the third-leading cause of blindness following glaucoma and cataract, with approximately 10 million people affected worldwide.

Market Snapshot - 2024-2031

Global Market Size

USD 455.8 million

Largest Segment

Penetrating keratoplasty

Fastest Growth

Penetrating keratoplasty

Growth Rate

7.5% CAGR

Global Corneal Transplant Market ($ Mn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Corneal Transplant Market Segmental Analysis

The corneal transplant market is segmented based on indication, type, end user, and region. Based on indications, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others. Based on type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty, corneal graft, corneal limbal stem cell transplant, and others. Based on end-user, the market is segmented into hospitals, eye clinics, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.  

Analysis by Indication 

The keratoconus category has emerged as the fastest-growing segment within the market, propelled by advancements in corneal implant procedures, notably Deep Anterior Lamellar Keratoplasty (DALK), and the presence of FDA-approved corneal implants. The innovative techniques associated with corneal implantation, such as DALK, have revolutionized the treatment landscape for keratoconus, offering patients more precise and tailored interventions. Additionally, the availability of FDA-approved corneal implants signifies a crucial endorsement of safety and efficacy, instilling confidence among healthcare providers and patients alike.  

The fungal corneal ulcer category has emerged as the top revenue generator, constituting a substantial 70.4% share of the total market income. This dominance is primarily attributed to the increasing prevalence of fungal corneal ulcers, a trend particularly pronounced in the aging population that faces a higher risk of developing such ocular conditions. As individuals age, the immune system's efficacy may decline, making the elderly more susceptible to fungal infections, including those affecting the cornea.

Analysis by Type 

The dominating force in the market, the penetrating keratoplasty segment, commands a significant 35% share of the total market revenue, equivalent to 0.14 billion. This method stands out as the standard approach for corneal transplant procedures due to its well-established safety profile and proven efficacy. Penetrating keratoplasty involves the complete replacement of the damaged or diseased cornea with a healthy donor cornea, addressing a range of cornea. The substantial market share attributed to this technique underscores its widespread acceptance and utilization within the medical community, affirming its status as a reliable and effective method for corneal transplantation. 

Experiencing the most rapid growth within the market, the endothelial keratoplasty category stands out due to the availability of alternative forms that consistently exhibit favorable outcomes. This unique approach to corneal transplant distinguishes itself by selectively replacing only the affected endothelial tissue, as opposed to the entire thickness of the cornea. The increasing popularity and accelerated growth of endothelial keratoplasty underscore its effectiveness and advantages, contributing to its preference among both healthcare providers and patients.

Global Corneal Transplant Market By Indication

To get detailed analysis on other segments, Request For Free Sample Report

Corneal Transplant Market Regional Insights

North America is poised for dominance, driven by a rising awareness of eye donation initiatives in the region and the active involvement of numerous organizations. Within North America, the US corneal transplant market has secured the largest market share, underscoring its prominence in the industry. Simultaneously, the corneal transplant market in Canada has demonstrated the fastest growth in the region. 

The Asia-Pacific corneal transplant market is anticipated to witness the most rapid Compound Annual Growth Rate (CAGR) from 2024 to 2031, driven by the escalating prevalence of ocular diseases attributable to lifestyle changes in the region. Factors such as diabetes, obesity, malnutrition, and other lifestyle-related illnesses have been associated with an increased incidence of vision impairments, fostering the demand for corneal transplant procedures. Notably, China has secured the largest market share within the corneal transplant market, highlighting its significant contribution to the regional landscape.

Global Corneal Transplant Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Corneal Transplant Market Dynamics

Drivers

Rising Prevalence of Eye Diseases 

  • The primary catalyst propelling the corneal implant market is the significant rise in the prevalence of corneal disorders. Various conditions, including but not limited to keratoconus, Fuchs dystrophy, keratitis, corneal scarring, corneal ulcers, and corneal edema, necessitate corneal transplantation as a crucial therapeutic intervention. Notably, statistics from the Corneal Research Foundation of America reveal a substantial burden, with approximately 50 to 200 out of every 100,000 individuals grappling with the challenging corneal disorder, keratoconus. This prevalence underscores the escalating demand for corneal implants, as these devices play a pivotal role in addressing the diverse spectrum of corneal disorders. The growing incidence of these conditions underscores the pressing need for advanced treatment modalities, thereby fueling the expansion of the corneal implant industry. 

Restraints 

High Cost of Treatment 

  • The corneal transplant market faces significant challenges with the high cost of treatment and a shortage of donor material emerging as key restraining factors to its growth. The expenses associated with corneal transplantation procedures, encompassing pre-operative assessments, surgical interventions, and post-operative care, contribute to the overall financial burden on patients and healthcare systems. The high cost may limit accessibility, particularly in regions with constrained healthcare resources.

Request Free Customization of this report to help us to meet your business objectives.

Corneal Transplant Market Competitive Landscape

The competitive environment of the global Corneal Transplant market  is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 

Top Player’s Company Profiles

  • Carl Zeiss Meditec AG (Germany) 
  • Alcon, Inc. (Switzerland) 
  • Bausch & Lomb Incorporated (United States) 
  • Abbott Medical Optics, Inc. (United States) 
  • CooperVision, Inc. (United States) 
  • STAAR Surgical Company (United States) 
  • Topcon Corporation (Japan) 
  • Johnson & Johnson Vision Care, Inc. (United States) 
  • Lumenis Ltd. (Israel) 
  • NIDEK Co., Ltd. (Japan) 
  • Haag-Streit AG (Switzerland) 
  • Ziemer Ophthalmic Systems AG (Switzerland) 
  • Essilor International S.A. (France) 
  • Allergan, Inc. (Ireland) 
  • HOYA Corporation (Japan) 
  • Menicon Co., Ltd. (Japan) 
  • Novartis AG (Switzerland) 
  • SynergEyes, Inc. (United States) 
  • Oculus, Inc. (United States) 
  • ZEISS Group (Germany)

Recent Developments

  • In April 2024, NHS Blood and Transplant (NHSBT) is initiating its inaugural cornea partnership with the renowned national optician chain, Specsavers, to emphasize the critical need for increased cornea donations. Collaborating with one of the largest and most esteemed retail brands, NHSBT intends to heighten understanding about the significance of corneal donation in facilitating the restoration of vision for numerous individuals awaiting corneal transplants throughout the UK. 
  • In January 2023, a Korean collaborative research group unveiled a novel tissue adhesive capable of repairing damaged corneas with a straightforward process of filling and light exposure. This innovative adhesive, unlike its predecessors, seamlessly integrates with surrounding tissues and facilitates tissue reconstruction within just three minutes of visible light irradiation.

Corneal Transplant Key Market Trends

  • The remarkable growth observed in the market for corneal implants can be primarily attributed to several key factors that collectively contribute to a heightened demand for these advanced medical devices. Notably, technological advancements in corneal implants have played a pivotal role in enhancing their efficacy and applicability in addressing various eye disorders. The escalating prevalence of the geriatric population is another significant driver, as this demographic is particularly susceptible to eye conditions such as Fuchs' dystrophy. The prevalence of late-onset Fuchs' endothelial dystrophy, a condition often affecting individuals over the age of 40, has been highlighted in a March 2020 article published in Progress in Retinal and Eye Research. 

Corneal Transplant Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The market is experiencing significant growth driven by several key factors. A notable contributor is the escalating prevalence of ophthalmic diseases, including conditions like keratoconus and infectious keratitis. This surge in disease prevalence has fueled the demand for advanced surgical interventions to address these eye conditions effectively. Moreover, there is a growing preference among consumers for minimally invasive surgical procedures, reflecting a broader trend in healthcare. The appeal of procedures that minimize trauma, reduce recovery times, and enhance overall patient comfort is driving the adoption of minimally invasive techniques in the field of ophthalmic surgery. Additionally, the rise in awareness regarding corneal transplants, with a focus on the aesthetic benefits they can provide, has further spurred market growth.

Report Metric Details
Market size value in 2022 USD 455.8 million
Market size value in 2031 USD 873.88 million
Growth Rate 7.5%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Indications
    • Fungal corneal ulcer, Bullous keratopathy, Keratoconus, Keratitis, Corneal stromal dystrophies, and Others
  • Type
    • Penetrating keratoplasty, Endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty (DSAEK), Corneal graft, Corneal limbal stem cell transplant, and Others
  • End-user
    • Hospitals, Eye clinics, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Carl Zeiss Meditec AG (Germany) 
  • Alcon, Inc. (Switzerland) 
  • Bausch & Lomb Incorporated (United States) 
  • Abbott Medical Optics, Inc. (United States) 
  • CooperVision, Inc. (United States) 
  • STAAR Surgical Company (United States) 
  • Topcon Corporation (Japan) 
  • Johnson & Johnson Vision Care, Inc. (United States) 
  • Lumenis Ltd. (Israel) 
  • NIDEK Co., Ltd. (Japan) 
  • Haag-Streit AG (Switzerland) 
  • Ziemer Ophthalmic Systems AG (Switzerland) 
  • Essilor International S.A. (France) 
  • Allergan, Inc. (Ireland) 
  • HOYA Corporation (Japan) 
  • Menicon Co., Ltd. (Japan) 
  • Novartis AG (Switzerland) 
  • SynergEyes, Inc. (United States) 
  • Oculus, Inc. (United States) 
  • ZEISS Group (Germany)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Corneal Transplant Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Corneal Transplant Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Corneal Transplant Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Corneal Transplant Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Corneal Transplant Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Corneal Transplant Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Corneal Transplant Market size was valued at USD 455.8 million in 2022 and is poised to grow from USD 489.99 million in 2023 to USD 873.88 million by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031). 

The competitive environment of the global Corneal Transplant market  is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.  'Carl Zeiss Meditec AG (Germany) ', 'Alcon, Inc. (Switzerland) ', 'Bausch & Lomb Incorporated (United States) ', 'Abbott Medical Optics, Inc. (United States) ', 'CooperVision, Inc. (United States) ', 'STAAR Surgical Company (United States) ', 'Topcon Corporation (Japan) ', 'Johnson & Johnson Vision Care, Inc. (United States) ', 'Lumenis Ltd. (Israel) ', 'NIDEK Co., Ltd. (Japan) ', 'Haag-Streit AG (Switzerland) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'Essilor International S.A. (France) ', 'Allergan, Inc. (Ireland) ', 'HOYA Corporation (Japan) ', 'Menicon Co., Ltd. (Japan) ', 'Novartis AG (Switzerland) ', 'SynergEyes, Inc. (United States) ', 'Oculus, Inc. (United States) ', 'ZEISS Group (Germany)'

The remarkable growth observed in the market for corneal implants can be primarily attributed to several key factors that collectively contribute to a heightened demand for these advanced medical devices. Notably, technological advancements in corneal implants have played a pivotal role in enhancing their efficacy and applicability in addressing various eye disorders. The escalating prevalence of the geriatric population is another significant driver, as this demographic is particularly susceptible to eye conditions such as Fuchs' dystrophy. The prevalence of late-onset Fuchs' endothelial dystrophy, a condition often affecting individuals over the age of 40, has been highlighted in a March 2020 article published in Progress in Retinal and Eye Research. 

North America is poised for dominance, driven by a rising awareness of eye donation initiatives in the region and the active involvement of numerous organizations. Within North America, the US corneal transplant market has secured the largest market share, underscoring its prominence in the industry. Simultaneously, the corneal transplant market in Canada has demonstrated the fastest growth in the region. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Corneal Transplant Market

Report ID: SQMIG35A2814

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE